Forgot your password?
The results showed that improvements observed with the drug were maintained at week 96
The inflammatory skin disease affects approximately 40 million people globally
Over 100,640 people are expected to be diagnosed with melanoma in the US this year
Approximately 40% of atopic dermatitis patients have moderate or severe symptoms
The chronic inflammatory skin condition is estimated to affect about 1% of the population in most studied countries
BNT111 in combination with Libtayo previously received fast track designation from the US Food and Drug Administration
The regulator is also reviewing the IL-31 inhibitor as a treatment for atopic dermatitis
The IL-13 inhibitor can now be used to treat adults and adolescents who are candidates for systemic therapy
The inflammatory disease can lead to complications including multisystem organ failure and sepsis
The oral JAK inhibitor is designed to interrupt the pathways that are thought to contribute to hair loss